Anti-VEGF Conbercept Developed For AMD Treatment | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Tuesday, February 11, 2014

Email

Comments

Ocular Surgery News

Phase 3 PHOENIX study data show a strong anatomic benefit of conbercept treatment, an anti-VEGF developed in China, a speaker said here.

Ectopia lentis in a patient with Marfan’s syndrome is characteristically in which direction:
1. inferotemporal
2. inferonasal
3. superotemporal
4. superonasal
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us